EUVIMEDEUVIMED entdecken
Crossref

Interface-Engineered Oral Hybrid Nanotherapeutics Combining Cerium Nanozymes and Extracellular Vesicles for Multimodal Regulation of Inflammatory Bowel Disease

Shengze Li, Peng Zhang iD, Ying Li, Meiqi Zhao, Huiting Deng

ACS Applied Materials & Interfaces · 18.02.2026 · 18 (6) · 10416-10427

DOI: 10.1021/acsami.5c25498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 06.02.2026. Verfasst von Shengze Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Life and Health Detection, Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin 300384…. Hauptthemen laut MEDLINE: Cerium, Inflammatory Bowel Diseases, Extracellular Vesicles, Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: First Affiliated Hospital of Anhui Medical University, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeriumInflammatory Bowel DiseasesExtracellular VesiclesNanoparticlesAnimalsMiceRAW 264.7 CellsOxidative StressDextran SulfateAdministration, OralMice, Inbred C57BLGastrointestinal MicrobiomeMesenchymal Stem CellsColitisHumansIntestinal Barrier Function

Stichwörter der Autor:innen

gut microbiotaimmunoregulationinflammatory bowel diseasenanotherapeuticoxidative stress

Substanzen

CeriumDextran Sulfate

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Life and Health Detection, Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin 300384, China.
  • People's Hospital of Chenggong District, Kunming Municipal, Kunming Medical University, Kunming 650599, China.
  • Department of gastroenterology & hepatology, Department of Cardiology, Tianjin First Center Hospital, Tianjin 300192, China.
  • Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin university, 83 Jintang Road, Tianjin 300170, China.

ORCID-Profile: Peng Zhang

Förderung

  • First Affiliated Hospital of Anhui Medical University
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Li, S., Zhang, P., Li, Y., Zhao, M., & Deng, H. (2026). Interface-Engineered Oral Hybrid Nanotherapeutics Combining Cerium Nanozymes and Extracellular Vesicles for Multimodal Regulation of Inflammatory Bowel Disease. ACS Applied Materials & Interfaces, 18(6), 10416-10427. https://doi.org/10.1021/acsami.5c25498

Vancouver

Li S, Zhang P, Li Y, Zhao M, Deng H. Interface-Engineered Oral Hybrid Nanotherapeutics Combining Cerium Nanozymes and Extracellular Vesicles for Multimodal Regulation of Inflammatory Bowel Disease. ACS Applied Materials & Interfaces. 2026;18(6):10416-10427. doi:10.1021/acsami.5c25498

BibTeX
@article{Li2026,
  author = {Li, Shengze and Zhang, Peng and Li, Ying and Zhao, Meiqi and Deng, Huiting},
  title = {Interface-Engineered Oral Hybrid Nanotherapeutics Combining Cerium Nanozymes and Extracellular Vesicles for Multimodal Regulation of Inflammatory Bowel Disease},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {10416--10427},
  doi = {10.1021/acsami.5c25498}
}
Kostenlos starten →